An agonist of the adenosine A2A receptor, CGS21680, promotes corneal epithelial wound healing via the YAP signalling pathway

IF 6.8 2区 医学 Q1 PHARMACOLOGY & PHARMACY British Journal of Pharmacology Pub Date : 2024-06-15 DOI:10.1111/bph.16468
Qiuqin Sun, Nan Jiang, Rui Yao, Yue Song, Zewen Li, Wei Wang, Jiangfan Chen, Wei Guo
{"title":"An agonist of the adenosine A2A receptor, CGS21680, promotes corneal epithelial wound healing via the YAP signalling pathway","authors":"Qiuqin Sun,&nbsp;Nan Jiang,&nbsp;Rui Yao,&nbsp;Yue Song,&nbsp;Zewen Li,&nbsp;Wei Wang,&nbsp;Jiangfan Chen,&nbsp;Wei Guo","doi":"10.1111/bph.16468","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Purpose</h3>\n \n <p>The adenosine A<sub>2A</sub> receptor (A<sub>2A</sub>R) is involved in various physiological and pathological processes in the eye; however, the role of the A<sub>2A</sub>R signalling in corneal epithelial wound healing is not known. Here, the expression, therapeutic effects and signalling mechanism of A<sub>2A</sub>R in corneal epithelial wound healing were investigated using the A<sub>2A</sub>R agonist CGS21680.</p>\n </section>\n \n <section>\n \n <h3> Experimental Approach</h3>\n \n <p>A<sub>2A</sub>R localization and expression during wound healing in the murine cornea were determined by immunofluorescence staining, quantitative reverse transcription polymerase chain reaction (RT-qPCR) and western blotting. The effect of CGS21680 on corneal epithelial wound healing in the lesioned corneal and cultured human corneal epithelial cells (hCECs) by modulating cellular proliferation and migration was critically evaluated. The role of Hippo–YAP signalling in mediating the CGS21680 effect on wound healing by pharmacological inhibition of YAP signalling was explored.</p>\n </section>\n \n <section>\n \n <h3> Key Results</h3>\n \n <p>A<sub>2A</sub>R expression was up-regulated after corneal epithelial injury. Topical administration of CGS21680 dose-dependently promoted corneal epithelial wound healing in the injured corneal epithelium by promoting cellular proliferation. Furthermore, CGS21680 accelerated the cellular proliferation and migration of hCECs in vitro. A<sub>2A</sub>R activation promoted early up-regulation and later down-regulation of YAP signalling molecules, and pharmacological inhibition of YAP signalling reverted CGS21680-mediated wound healing effect in vivo and in vitro.</p>\n </section>\n \n <section>\n \n <h3> Conclusion and Implications</h3>\n \n <p>A<sub>2A</sub>R activation promotes wound healing by enhancing cellular proliferation and migration through the YAP signalling pathway. A<sub>2A</sub>Rs play an important role in the maintenance of corneal epithelium integrity and may represent a novel therapeutic target for facilitating corneal epithelial wound healing.</p>\n </section>\n </div>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":6.8000,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bph.16468","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Purpose

The adenosine A2A receptor (A2AR) is involved in various physiological and pathological processes in the eye; however, the role of the A2AR signalling in corneal epithelial wound healing is not known. Here, the expression, therapeutic effects and signalling mechanism of A2AR in corneal epithelial wound healing were investigated using the A2AR agonist CGS21680.

Experimental Approach

A2AR localization and expression during wound healing in the murine cornea were determined by immunofluorescence staining, quantitative reverse transcription polymerase chain reaction (RT-qPCR) and western blotting. The effect of CGS21680 on corneal epithelial wound healing in the lesioned corneal and cultured human corneal epithelial cells (hCECs) by modulating cellular proliferation and migration was critically evaluated. The role of Hippo–YAP signalling in mediating the CGS21680 effect on wound healing by pharmacological inhibition of YAP signalling was explored.

Key Results

A2AR expression was up-regulated after corneal epithelial injury. Topical administration of CGS21680 dose-dependently promoted corneal epithelial wound healing in the injured corneal epithelium by promoting cellular proliferation. Furthermore, CGS21680 accelerated the cellular proliferation and migration of hCECs in vitro. A2AR activation promoted early up-regulation and later down-regulation of YAP signalling molecules, and pharmacological inhibition of YAP signalling reverted CGS21680-mediated wound healing effect in vivo and in vitro.

Conclusion and Implications

A2AR activation promotes wound healing by enhancing cellular proliferation and migration through the YAP signalling pathway. A2ARs play an important role in the maintenance of corneal epithelium integrity and may represent a novel therapeutic target for facilitating corneal epithelial wound healing.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腺苷 A2A 受体激动剂 CGS21680 可通过 YAP 信号通路促进角膜上皮伤口愈合。
背景和目的:腺苷 A2A 受体(A2AR)参与眼部的各种生理和病理过程,但 A2AR 信号在角膜上皮伤口愈合中的作用尚不清楚。在此,我们使用 A2AR 激动剂 CGS21680 研究了 A2AR 在角膜上皮伤口愈合中的表达、治疗作用和信号机制:实验方法:通过免疫荧光染色、定量反转录聚合酶链反应(RT-qPCR)和免疫印迹法测定小鼠角膜伤口愈合过程中A2AR的定位和表达。通过调节细胞增殖和迁移,对 CGS21680 对病变角膜和培养的人角膜上皮细胞(hCECs)角膜上皮伤口愈合的影响进行了严格评估。通过药理抑制 YAP 信号,探讨了 Hippo-YAP 信号在介导 CGS21680 对伤口愈合影响中的作用:角膜上皮损伤后 A2AR 表达上调。通过促进细胞增殖,局部给药 CGS21680 可剂量依赖性地促进损伤角膜上皮的伤口愈合。此外,CGS21680 还能加速体外 hCECs 的细胞增殖和迁移。A2AR 激活可促进 YAP 信号分子的早期上调和后期下调,而药理抑制 YAP 信号可恢复 CGS21680 在体内和体外介导的伤口愈合效应:A2AR 激活可通过 YAP 信号通路促进细胞增殖和迁移,从而促进伤口愈合。A2AR 在维持角膜上皮完整性方面发挥着重要作用,可能是促进角膜上皮伤口愈合的新型治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
期刊最新文献
Vortioxetine reduces the development of pain-related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down-regulation Selective modulation of epileptic tissue by an adenosine A3 receptor-activating drug Contribution of T-type calcium channel isoforms to cold and mechanical sensitivity in naïve and oxaliplatin-treated mice of both sexes Mitigating off-target effects of small RNAs: conventional approaches, network theory and artificial intelligence Immune regulatory and anti-resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1